1. Adler S, Waterman ML, He X, Rosenfeld MG (1988) Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain. Cell 52:685–695.
2. Altucci L, Addeo R, Cicatiello L, Dauvois S, Malcolm GP, Truss M, Beato M, Sica V, Bresciani F, Weisz A (1996) 17β-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells. Oncogene 12:2315–2324.
3. Altucci L, Addeo R, Cicatiello L, Germano D, Pacilio C, Battista T, Cancemi M, Belsito Patrizzi V, Bresciani F, Weisz A (1997) Estrogen induces early and timed activation of cyclin-dependent kinases 4,5 and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus. Endocrinology 138:978–984.
4. Ambrosino C, Cicatiello L, Cobellis G, Addeo R, Sica V, Bresciani F, Weisz A (1993) Functional interference between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription. Mol Endocrinol 7:1472–1483.
5. Anolik JH, Klinge CM, Bambara RA, Hilf R (1993) Differential impact of flanking sequences on estradiol-vs. 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA. J Steroid Biochem Mol Biol 46:713–730.